Lupin inks licensing pact with Japan-based I#39;rom Group

Under the terms of the agreement, I#39;rom along with the Mumbai-based drugmaker will conduct clinical trials, register, distribute and market biosimilar Denosumab in Japan on an exclusive basis.

from Moneycontrol Business News https://ift.tt/4T7IC1X